Search 
Friday, July 25, 2014 ..:: Protocols » Cooperative Group ::.. Register  Login
 Cooperative Group Trials Active within the CTN Minimize
Below are the NCI Cooperative Group active protocol list within the HCC Clinical Trials Network program. If you wish to access the cooperative group protocol documents and updates, please use the cooperative group links below. Protocol documents are available to cooperative group members who have an active username and password. If you are having difficulty accessing a protocol document, contact your research coordinator or the Network office.

 Print   
 Cooperative Group Active Trial Listing Minimize

last updated December 18, 2013


Disease Site

Study Number

Protocol Title

Participating Centers

Breast
SWOG 1007
A Phase III Randomized clinical Trial of Standard Adjuvant Endocrine Therapy /- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less

Georgetown Hospital System
PI:  David Lee Milling, MD
Thoracic
ECOG 5508
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

Georgetown Hospital System
PI:  David Lee Milling, MD 
Breast

NSABP B-47

A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemo Alone (Six Cycles of Docetaxel Plus Cyclophosphamdide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemo Plus Trastuzumab in Women with Node-Positive or High Risk Node-Negative HER2-Low Invasive Breast Cancer
Georgetown Hospital System
PI:  David Lee Milling, MD 
Breast
NSABP B-49
A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Self Regional Healthcare
PI:  Joanna Metzner-Sadurski, MD
(Closed to Enrollment)

Breast

ACOSOG 11102

Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients with Multiple Ipsilateral Breast Cancers (MIBC)

Hilton Head Regional Medical Center
PI:  Virginia Hermann, MD

GI

SWOG S0820

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)

Self Regional Healthcare
PI:  Joanna Metzner-Sadurski, MD

GI

CALGB 80702

A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

Georgetown Hospital System
PI:  David Lee Milling, MD 

Breast

NSABP B-43

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Self Regional Healthcare
PI:  E. Clint Wood, MD

GU

RTOG 0815

A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

Self Regional Healthcare
PI:  E. Clint Wood, MD
GU

RTOG 0924
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

Self Regional Healthcare
PI:  E. Clint Wood, MD

Breast

SWOG S1202

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer


Self Regional Healthcare
PI:  Joanna Metzner-Sadurski, MD
Breast

SWOG S1207

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy /- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer

Self Regional Healthcare
PI:  Joanna Metzner-Sadurski, MD

Breast

ECOG E1Z11

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Self Regional Healthcare
PI:  Joanna Metzner-Sadurski, MD
 

Head & Neck

RTOG 1016

Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Self Regional Healthcare
PI:  Joanna Metzner-Sadurski, MD
(Closed to Accrual)

Breast

ACOSOG Z1071

A Phase II Study Evaluating the Role of Sentinel Lymph Node Surgery and Axillary Lymph Node Dissection Following Preoperative Chemotherapy in Women with Node Positive Breast Cancer (T0-4, N1-2, M0) at Initial Diagnosis

Hilton Head Regional Medical Center
PI:  Virginia Hermann, MD

Breast

ACOSOG Z1031

A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane (25 mg daily), Letrozole (2.5 mg), or Anastrozole (1 mg) in Postmenopausal Women with Clinical Stage II and III Estrogen Receptor Positive Breast Cancer

Hilton Head Regional Medical Center
PI:  Virginia Hermann, MD

Breast

SWOG S0812

A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer, Phase IIb

Self Regional Healthcare
PI: Joanna Metzner-Sadurski, MD
(Closed by Site)

GU

 SWOG S0931

 EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

Self Regional Healthcare
PI: Joanna Metzner-Sadurski, MD

GYN

RTOG 1203

A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)

Self Regional Healthcare
PI: E. Clint Wood, MD

GU

 SWOG S1216

A Phase III Randomized Trial Comparing Androgen Deprivation Therapy TAK-700 with Androgen Deprivation Therapy Bicalutamide in Patients with Newly-Diagnosed Metastatic Hormone-Sensitive Prostate Cancer

Self Regional Healthcare
PI: Joanna Metzner-Sadurski, MD

 Print   
 Cooperative Groups Studies - Closed to Enrollment Minimize

 Print   
 Cooperative Group Affiliates Newsletter Minimize

CollectionsCollections CategoriesCategories SearchSearch 

  Cooperative Group Newsletters

 
Description        Last ModifiedAuthorCreatedSize
Details201212/19/2013Mike Laskavy12/19/2013
Details201312/19/2013Mike Laskavy12/19/2013

 Print   
 Cooperative Group Websites Minimize

 Print   
Copyright 2008 by Hollings Cancer Center   Terms Of Use  Privacy Statement